Characteristics, safety and cost‐effectiveness analysis of self‐administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States

医学 急诊医学 静脉治疗 抗生素 回廊的 重症监护医学 外科 生物 微生物学
作者
Sam Karimaghaei,Aishwarya Rao,Juliet Chijioke,Natalie Finch,Masayuki Nigo
出处
期刊:Journal of Clinical Pharmacy and Therapeutics [Wiley]
卷期号:47 (2): 211-217 被引量:22
标识
DOI:10.1111/jcpt.13550
摘要

WHAT IS KNOWN AND OBJECTIVE: Outpatient parenteral antibiotic therapy (OPAT) is an attractive option for patients who require parenteral antimicrobials as outpatients. Few OPAT studies have assessed the impact of IV antibiotic therapy via elastomeric continuous pumps, with most having been conducted outside the United States and few in county hospitals. The OPAT program in Harris Health system, the county hospital system of Houston, Texas, United States, has implemented a disposable elastomeric continuous infusion pump (eCIP) for self-administered intravenous antibiotics (s-OPAT) since December 2018. Our goal was to describe the clinical characteristics of patients discharged with an eCIP, as well as the safety and cost-effectiveness of this pump. METHODS: We retrospectively analysed patients discharged from Harris Health hospitals between 12/2018 and 02/2021 with s-OPAT via eCIP at home. We extracted various patient characteristics and outcomes related to OPAT. RESULTS AND DISCUSSION: Among 481 OPAT patients during the study period, 91 patients received s-OPAT via eCIP. A total of 1925 days of s-OPAT were administered at home, with a median duration of 12 days. Eighty-three patients (93.4%) achieved a cure from infection, six patients (6.6%) had side effects, and nine patients (9.9%) experienced 30-day hospital readmission. Twenty-two patients (24.2%) presented to the ED during s-OPAT, with 13 patients (14.3%) presenting with PICC line concerns. We estimated that s-OPAT via eCIP saved $2,360,500 to $3,503,900 compared to inpatient-only therapy. WHAT IS NEW AND CONCLUSION: Our study showed that patients with s-OPAT via eCIP had a high cure rate with a relatively low incidence of side effects and 30-day hospital readmission. ED visits during therapy were relatively high, which indicates the necessity of close patient monitoring via the OPAT program. eCIP appears to be a good option to facilitate an early disposition of patients in county hospitals.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
爆米花应助Lmey采纳,获得10
刚刚
zimu012发布了新的文献求助10
1秒前
1秒前
愉快的夏菡完成签到,获得积分20
2秒前
2秒前
2秒前
2秒前
xiaokezhang发布了新的文献求助10
2秒前
3秒前
学术小白完成签到,获得积分10
3秒前
从容的梦琪完成签到,获得积分10
3秒前
zoerist发布了新的文献求助10
3秒前
Lucas应助单半青采纳,获得10
4秒前
4秒前
yshhhhhhhh完成签到,获得积分10
4秒前
4秒前
4秒前
5秒前
5秒前
lsw发布了新的文献求助10
5秒前
TT发布了新的文献求助10
5秒前
5秒前
jiaozi关注了科研通微信公众号
6秒前
7秒前
生蚝大王应助1214采纳,获得10
7秒前
里奥发布了新的文献求助10
7秒前
14发布了新的文献求助10
7秒前
月圆夜发布了新的文献求助10
7秒前
crisp完成签到,获得积分10
7秒前
7秒前
嘉心糖举报espresso求助涉嫌违规
8秒前
Asystasia7发布了新的文献求助10
8秒前
8秒前
8秒前
8秒前
科研的鱼发布了新的文献求助10
8秒前
大水完成签到 ,获得积分10
8秒前
8秒前
科研通AI6.2应助yu001采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
模型平均及其应用 900
Nondestructive Testing Handbook: Vol. 4, Thermal and Infrared Testing (IR), 4th ed 800
Évora na Idade Média 555
作者名:Kristopher P. Plain,悉尼大学的,目前只能查到其四篇论文,想找到其博士论文 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7343494
求助须知:如何正确求助?哪些是违规求助? 8956056
关于积分的说明 19015587
捐赠科研通 6995622
什么是DOI,文献DOI怎么找? 3219479
关于科研通互助平台的介绍 2384627
邀请新用户注册赠送积分活动 2199653